Diabetes Mellitus, Type 2Diabetes MellitusDiabetes Mellitus, Type 1Liver TransplantationTransplantation, HomologousDiabetes ComplicationsKidney TransplantationDiabetes Mellitus, ExperimentalBone Marrow TransplantationHematopoietic Stem Cell TransplantationBlood GlucoseHeart TransplantationDiabetes, GestationalTransplantation, AutologousLung TransplantationHypoglycemic AgentsRisk FactorsInsulinStem Cell TransplantationGraft SurvivalIslets of Langerhans TransplantationPancreas TransplantationTransplantation ConditioningOrgan TransplantationHemoglobin A, GlycosylatedGraft RejectionTreatment OutcomeRetrospective StudiesTime FactorsTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationHyperglycemiaFollow-Up StudiesImmunosuppressive AgentsGlucose Tolerance TestDiabetic NephropathiesTransplantation ChimeraDiabetic AngiopathiesDiabetic NeuropathiesIslets of LangerhansProspective StudiesInsulin ResistanceTransplantation, IsogeneicGraft vs Host DiseaseDiabetic RetinopathyPrevalenceLiving DonorsTransplantation, HeterotopicObesityIncidenceCord Blood Stem Cell TransplantationCohort StudiesStreptozocinHeart-Lung TransplantationPregnancy in DiabeticsCase-Control StudiesPostoperative ComplicationsTissue and Organ ProcurementDiabetic KetoacidosisBody Mass IndexImmunosuppressionKidney Failure, ChronicTransplantation ToleranceBiological MarkersHypertensionRisk AssessmentHistocompatibility TestingInsulin-Secreting CellsLiver FailureCardiovascular DiseasesRecurrenceC-PeptidePeripheral Blood Stem Cell TransplantationPrediabetic StateGlucose IntoleranceHypoglycemiaAge FactorsMultivariate AnalysisGlucoseFetal Tissue TransplantationSulfonylurea CompoundsSurvival AnalysisTacrolimusDiabetes InsipidusMetforminMice, Inbred NODSurvival RateBlood Glucose Self-MonitoringSkin TransplantationAlbuminuriaWaiting ListsFastingPrognosisTransplantation, HeterologousPregnancyCross-Sectional StudiesCyclosporineUnited States